Figueroa 2016.
| Methods |
Study design (CBA, ITS): CBA Allocation linked to study or natural experiment: natural experiment Selection of hospitals (intervention/control): comparison 1: all conditions targeted by P4P/selected conditions not targeted by P4P; comparison 2: acute care hospitals/hospitals in another region and critical access hospitals Unit of allocation (region, hospital, country): comparison 1: individual level; comparison 2: region and hospital type Nature of desired change: introduction Data source: 100% Medicare inpatient claims data from 2008 through 2013 Unit of analyses: comparison 1: individual; comparison 2: hospital Number of measurements (before, transition, after, unit [e.g. years]): 14/NA/10 (quarter) Statistical analyses: ‐ Method: difference‐in‐difference; random effects linear spline regression ‐ Adjustment factors: comorbidities, seasonal variation |
|
| Participants |
Country/region/setting: USA/whole country/hospitals Health system characteristics: Medicare Number of hospitals included in the analysis (intervention/control): 2919/1348 Characteristics of hospitals (before [whole population], intervention/control): acute care hospitals/hospitals in another region and critical access hospitals
Number of patients included in the analysis (intervention/control): 2,252,818/177,800 Characteristics of patients (intervention/control): acute myocardial infarction, congestive heart failure, and pneumonia/stroke, sepsis, gastroenteritis and esophagitis, gastrointestinal bleed, urinary tract infection, metabolic disorder, arrhythmia, renal failure
Existing/other quality programs: not reported Other relevant context information: none |
|
| Interventions | Rewards or penalizes hospitals based on their performance on multiple domains of care, including clinical processes, clinical outcomes (e.g. 30‐day mortality for acute myocardial infarction, pneumonia, and heart failure), patient experience, and, latter, cost efficiency. Performance is determined based on hospitals’ absolute achievement compared with the national average, or improvement compared with their own performance in the baseline period, depending on which is greater. Funding is designed to be budget neutral; Medicare withholds a percentage of inpatient payments to prospectively paid hospitals and then redistributes this money back to hospitals based on their performance. National in scope and obligatory. Control: Comparison 1: No P4P Comparison 2: Probably mixture of basic P4P (incentives of hospitals without penalties) and no P4P |
|
| Outcomes | Mortality (30 days) | |
| Notes |
Funding/conflict of interest: work received no support from any organization; authors no financial relationships with any organizations that might have an interest in the submitted work in the previous 3 years; no other relationships or activities that could appear to have influenced the submitted work Information for subgroup analysis: low baseline performance Other comments: ‐ |
|
| Risk of bias | ||
| Bias | Authors' judgement | Support for judgement |
| Random sequence generation (selection bias) | High risk | CBA |
| Allocation concealment (selection bias) | High risk | CBA |
| Blinding of participants and personnel (performance bias) All outcomes | High risk | CBA, intervention cannot be blinded |
| Blinding of outcome assessment (detection bias) Objective outcomes | Low risk | Mortality |
| Incomplete outcome data (attrition bias) All outcomes | Unclear risk | Not sufficiently reported |
| Selective reporting (reporting bias) | Low risk | No indication for selective reporting |
| Other bias | Low risk | No evidence of other risk of bias |
| Baseline outcomes similar All outcomes | High risk | Difference in baseline outcomes |
| Free of contamination | High risk | Comparison 1: high risk, allocation on individual level and intervention cannot be blinded Comparison 2: low risk, allocation on hospital level |
| Baseline characteristics similar | High risk | Difference in baseline characteristics |